GFOR

NYSE

Graf Acquisition Corp. IV

SectorFinanceIndustryBlank ChecksIPO2021

News25/Ratings0

Graf Acquisition Corp. IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in The Woodlands, Texas.

Latest news

25 items

799dINSIDER
SEC Form 4 filed by Scott Kathleen D.
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
799dINSIDER
SEC Form 4 filed by Kim Yong Man
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
799dINSIDER
SEC Form 4 filed by Song Paul Y.
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
799dINSIDER
SEC Form 4 filed by Gagnon Pierre
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
799dINSIDER
SEC Form 4 filed by Klowden Michael
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
799d13D/G
SEC Form SC 13G filed by Graf Acquisition Corp. IV
SC 13G - NKGen Biotech, Inc. (0001845459) (Subject)
799d13D/G
SEC Form SC 13G/A filed by Graf Acquisition Corp. IV (Amendment)
SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
801dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
805dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Leadership Update
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
806d13D/G
SEC Form SC 13G/A filed by Graf Acquisition Corp. IV (Amendment)
SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)
822dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
833dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
836dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
847dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
848dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
848dSEC
Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - NKGen Biotech, Inc. (0001845459) (Filer)
856d13D/G
SEC Form SC 13D/A filed by Graf Acquisition Corp. IV (Amendment)
SC 13D/A - NKGen Biotech, Inc. (0001845459) (Subject)
860dINSIDER
Park Sangwoo gifted 2,500,000 shares (SEC Form 4)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
860dSEC
SEC Form S-1/A filed by Graf Acquisition Corp. IV (Amendment)
S-1/A - NKGen Biotech, Inc. (0001845459) (Filer)
868dINSIDER
Song Paul Y. bought $500 worth of shares (151 units at $3.30), increasing direct ownership by 0.09% to 171,121 units (SEC Form 4)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
870dINSIDER
Song Paul Y. bought $850 worth of shares (268 units at $3.17), increasing direct ownership by 0.16% to 170,969 units (SEC Form 4)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
870dINSIDER
Graf James A bought $2,172 worth of shares (670 units at $3.24), increasing direct ownership by 2,913% to 693 units (SEC Form 4)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
876dSEC
SEC Form S-1/A filed by Graf Acquisition Corp. IV (Amendment)
S-1/A - NKGen Biotech, Inc. (0001845459) (Filer)
877dINSIDER
Song Paul Y. bought $701 worth of shares (244 units at $2.88), increasing direct ownership by 0.14% to 170,701 units (SEC Form 4)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)
883dINSIDER
Graf James A bought $67 worth of shares (23 units at $2.93) (SEC Form 4)
4 - NKGen Biotech, Inc. (0001845459) (Issuer)